Related Experiment Video
Updated: Apr 27, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.0K
IIIa deleted adenovirus as a single-cycle genome replicating vector
Catherine M Crosby1, Michael A Barry2
1Virology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, MN 55902, USA.
Virology
|July 5, 2014
Summary
A novel single cycle adenovirus (SC-Ad) vector replicates transgenes for high expression, offering a safer alternative to replication-competent adenoviruses. This advancement holds promise for improved vaccine and therapeutic applications.
Area of Science:
- Gene therapy
- Virology
- Adenovirus vector development
Background:
- Replication-competent adenovirus (RC-Ad) vectors provide robust transgene expression through replication but pose risks of adenoviral infection.
- Replication-defective adenovirus (RD-Ad) vectors are safer but yield significantly lower transgene products.
- A need exists for safer, high-expression adenoviral vectors for therapeutic and vaccine applications.
Purpose of the Study:
- To engineer a single cycle adenovirus (SC-Ad) vector that achieves high transgene expression while mitigating the risks associated with replication-competent adenoviruses.
- To evaluate the safety and efficacy of the novel SC-Ad vector compared to existing adenovirus vector systems.
Main Methods:
- Development of a single cycle adenovirus (Ad6-ΔIIIa) by deleting the capsid protein IIIa in adenovirus serotype 6, rendering it unable to form mature virions.
- Production of Ad6-ΔIIIa in specialized cell lines expressing protein IIIa.
- In vitro and in vivo assessments of transgene expression levels and viral replication capabilities in human and mouse cells and in mice.
Main Results:
- Ad6-ΔIIIa successfully replicates its genome and transgene in normal cells but is incapable of DNA packaging or mature virus formation, ensuring safety.
- SC-Ad and RC-Ad vectors demonstrated hundreds of times higher transgene expression compared to RD-Ad vectors in both in vitro and in vivo models.
- The Ad6-ΔIIIa vector showed significantly enhanced transgene expression over RD-Ad, approaching levels seen with RC-Ad, but without the associated infection risk.
Conclusions:
- Single cycle adenoviruses (SC-Ads), exemplified by Ad6-ΔIIIa, represent a promising class of amplifying vectors that balance robust transgene expression with enhanced safety.
- The Ad6-ΔIIIa vector's ability to replicate transgenes without causing infection makes it a potentially superior platform for vaccine and gene therapy applications.
- Further research into SC-Ads could lead to safer and more effective adenoviral vector-based therapies and vaccines.
Keywords:
AdenovirusAmplificationGene therapyReplication-competentReplication-defectiveSingle-cycleVaccinesMore Related Videos
Related Concept Videos
01:29Viruses with RNA Genomes
1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
01:10Retrovirus Life Cycles
42.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K